Table 3.
Allergenicity and antigenicity assessment of predicted B-cell epitopes.
| Protein | Algorithms | Top peptide sequence | Allergenicity | Vaxijen score |
|---|---|---|---|---|
| Spike glycoprotein | Bepipred Linear Epitope Prediction 2.0 | IRGDEVRQIAPGQTGKIADYNYK | Non-allergen | 1.0547 |
| Emini surface accessibility prediction | GDEVRQ | Non-allergen | 0.6701 | |
| Kolaskar and Tongaonkar antigenicity | VRQIAPG | Non-allergen | 1.2611 | |
| Membrane glycoprotein | Bepipred Linear Epitope Prediction 2.0 | MWSFNPETN | Non-allergen | 0.5509 |
| Emini surface accessibility prediction | LFARTRSMWSFNPET | Non-allergen | 0.9033 | |
| Kolaskar and Tongaonkar antigenicity | AMACLVGLM | Non-allergen | 0.6251 | |
| Envelope protein | Bepipred Linear Epitope Prediction 2.0 | YVYSRVKNLNSSRVP | Non-allergen | 0.4492 |
| Emini surface accessibility prediction | PSFYVYSRVKNLNSSRVP | Non-allergen | 0.5796 | |
| Kolaskar and Tongaonkar antigenicity | VNSVLLFLAFVVFLLVTLA | Non-allergen | 0.5893 | |
| Nucleocapsid protein | Bepipred Linear Epitope Prediction 2.0 | PGSSRGTSPARMAGNGG | Non-allergen | 0.3854 |
| Emini surface accessibility prediction | TEPKKDKKKKAD | Non-allergen | 0.2378 | |
| Kolaskar and Tongaonkar antigenicity | HWPQIAQFAPSASAF | Non-allergen | 0.4320 |